###begin article-title 0
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
###end article-title 0
###begin p 1
The extent to which myelin-specific Th1 and Th17 cells contribute to the pathogenesis of experimental autoimmune encephalomyelitis (EAE) is controversial. Combinations of interleukin (IL)-1beta, IL-6, and IL-23 with transforming growth factor beta were used to differentiate myelin-specific T cell receptor transgenic T cells into Th17 cells, none of which could induce EAE, whereas Th1 cells consistently transferred disease. However, IL-6 was found to promote the differentiation of encephalitogenic Th17 cells. Further analysis of myelin-specific T cells that were encephalitogenic in spontaneous EAE and actively induced EAE demonstrated that T-bet expression was critical for pathogenicity, regardless of cytokine expression by the encephalitogenic T cells. These data suggest that encephalitogenicity of myelin-specific T cells appears to be mediated by a pathway dependent on T-bet and not necessarily pathway-specific end products, such as interferon gamma and IL-17.
###end p 1
###begin p 2
###xml 612 613 612 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 651 678 651 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">McDonald and Swanborg, 1988</xref>
###xml 680 697 680 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Ando et al., 1989</xref>
###xml 699 722 699 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Waldburger et al., 1996</xref>
###xml 724 741 724 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">Yura et al., 2001</xref>
###xml 743 768 743 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Lovett-Racke et al., 2004</xref>
###xml 770 788 770 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
###xml 831 832 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1211 1230 1207 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Olsson et al., 1990</xref>
###xml 1232 1248 1228 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Sun et al., 1991</xref>
###xml 1250 1270 1246 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Voskuhl et al., 1993</xref>
###xml 1272 1292 1268 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Pelfrey et al., 2000</xref>
###xml 1554 1577 1550 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Allegretta et al., 1990</xref>
###xml 1579 1604 1575 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Lovett-Racke et al., 1998</xref>
###xml 1606 1624 1602 1620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Burns et al., 1999</xref>
###xml 1991 2013 1983 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Bielekova et al., 2000</xref>
###xml 541 544 <span type="species:ncbi:31658">CFA</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 936 944 <span type="species:ncbi:9606">patients</span>
###xml 1001 1009 <span type="species:ncbi:9606">patients</span>
###xml 1099 1107 <span type="species:ncbi:9606">patients</span>
###xml 1161 1169 <span type="species:ncbi:9606">patients</span>
###xml 1436 1444 <span type="species:ncbi:9606">patients</span>
###xml 1825 1833 <span type="species:ncbi:9606">patients</span>
Experimental autoimmune encephalomyelitis (EAE) has been used as a model for multiple sclerosis (MS) for over four decades. Our understanding of EAE and the immune cells that mediate the pathology of the disease has grown tremendously during this time. However, as the field of immunology evolves, many of the fundamental observations in EAE are questioned and revisited to further our understanding of EAE and ultimately enhance our understanding of MS. Although EAE was initially induced by immunization with myelin proteins emulsified in CFA, it can also be induced by adoptive transfer of myelin-specific CD4+ Th1 cells into naive recipient mice (McDonald and Swanborg, 1988; Ando et al., 1989; Waldburger et al., 1996; Yura et al., 2001; Lovett-Racke et al., 2004; Gocke et al., 2007). The observation that myelin-specific CD4+ Th1 cells were sufficient to induce EAE focused MS research on these IFN-gamma-producing T cells in MS patients. Although myelin-specific T cells were found in both MS patients and healthy individuals, which raised questions as to the relevance of these cells in MS patients, it does appear that myelin-specific T cells from MS patients are more likely to have a Th1 phenotype (Olsson et al., 1990; Sun et al., 1991; Voskuhl et al., 1993; Pelfrey et al., 2000). Subsequently, several studies demonstrated that although healthy individuals had myelin-specific T cells, these cells were naive, whereas MS patients had activated and memory myelin-specific T cells, indicating that these cells had been previously activated (Allegretta et al., 1990; Lovett-Racke et al., 1998; Burns et al., 1999). In addition, a clinical trial with an altered peptide ligand from myelin basic protein (MBP), which was intended to down-regulate myelin-specific T cells, actually exacerbated disease in several MS patients, which was associated with increased frequency of MBP-specific T cells that produced IFN-gamma, suggesting that MS is mediated by myelin-specific Th1 cells (Bielekova et al., 2000).
###end p 2
###begin p 3
###xml 212 231 200 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Lublin et al., 1993</xref>
###xml 233 252 221 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Ferber et al., 1996</xref>
###xml 254 275 242 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Heremans et al., 1996</xref>
###xml 277 300 265 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">Willenborg et al., 1996</xref>
###xml 336 337 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 472 488 456 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Chu et al., 2000</xref>
###xml 714 715 690 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 780 798 756 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Racke et al., 1994</xref>
###xml 800 818 776 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Racke et al., 1995</xref>
###xml 820 845 796 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Lovett-Racke et al., 2004</xref>
###xml 991 1011 967 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Chitnis et al., 2001</xref>
###xml 1013 1034 989 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Bettelli et al., 2004</xref>
###xml 1036 1061 1012 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Lovett-Racke et al., 2004</xref>
###xml 1063 1080 1039 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Nath et al., 2006</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
As a result, several studies focused on IFN-gamma as the pathogenic molecule in EAE and MS. Surprisingly, IFN-gamma-deficient mice and mice given antibodies to neutralize IFN-gamma were still susceptible to EAE (Lublin et al., 1993; Ferber et al., 1996; Heremans et al., 1996; Willenborg et al., 1996). The number of myelin-specific CD4+ T cells was expanded in these mice, which may have occurred because of the loss of regulatory cells that were dependent on IFN-gamma (Chu et al., 2000). However, several studies that specifically suppressed IFN-gamma in the myelin-specific T cells before transfer into recipient mice demonstrated that altering the signaling pathway that results in IFN-gamma production in CD4+ T cells decreases the encephalitogenic capacity of these cells (Racke et al., 1994; Racke et al., 1995; Lovett-Racke et al., 2004). In addition, STAT4 and T-bet, transcription factors in the Th1 cell differentiation pathway, have been shown to be critical for EAE induction (Chitnis et al., 2001; Bettelli et al., 2004; Lovett-Racke et al., 2004; Nath et al., 2006). Together, these data suggest that the differentiation pathway that generates Th1 cells may be important in encephalitogenicity, but the downstream production of IFN-gamma by myelin-specific T cells may not be critical.
###end p 3
###begin p 4
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 230 251 230 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 455 472 455 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Lock et al., 2002</xref>
###xml 714 732 714 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
###xml 734 751 734 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Lees et al., 2008</xref>
###xml 868 889 868 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Komiyama et al., 2006</xref>
###xml 891 908 891 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Haak et al., 2009</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
More recently, a new phenotype of CD4+ T cells was described in EAE that appears to be pathogenic. Stimulation of myelin-specific T cells from myelin-immunized mice with IL-23 promotes the expansion of T cells that express IL-17 (Langrish et al., 2005). Transfer of these myelin-specific IL-17-producing T cells, called Th17 cells, into naive mice induced EAE. In addition, microarray analysis of MS tissues indicates that IL-17 is present in MS lesions (Lock et al., 2002). We and others have shown that Th17 cells are found in the central nervous system (CNS) of mice after adoptive transfer of myelin-specific Th1 cells; however, the Th17 cells are derived from the recipient and not the transferred Th1 cells (Gocke et al., 2007; Lees et al., 2008). In addition, IL-17-deficient mice developed EAE, although disease severity is reduced and disease course altered (Komiyama et al., 2006; Haak et al., 2009). These studies have raised the question as to whether the pathogenic T cells in EAE and MS are actually Th1 or Th17 cells, or whether both populations contribute to the disease.
###end p 4
###begin p 5
###xml 112 113 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 148 169 145 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bettelli et al., 2006</xref>
###xml 171 190 168 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Mangan et al., 2006</xref>
###xml 192 213 189 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Veldhoen et al., 2006</xref>
###xml 510 531 503 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">McGeachy et al., 2007</xref>
###xml 533 554 526 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Stromnes et al., 2008</xref>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
Several studies have defined cytokines, primarily IL-6 and TGF-beta, which can induce the differentiation of CD4+ T cells into Th17 cells in vitro (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006). However, it has not been demonstrated whether pure populations of myelin-specific Th17 cells can induce EAE, because previous studies have used lymphocytes from immunized mice that have been skewed in vitro to enhance either IFN-gamma or IL-17 expression, but not exclude the other population (McGeachy et al., 2007; Stromnes et al., 2008). In the present study, we use TCR transgenic T cells specific for MBP Ac1-11 to study the differentiation of Th17 cells and their ability to induce EAE. In addition, we characterized the pathogenic autoreactive T cells in both induced and spontaneous EAE.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
IL-6 + TGF-beta fail to generate encephalitogenic Th17 cells
###end title 7
###begin p 8
###xml 93 114 93 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bettelli et al., 2006</xref>
###xml 116 135 116 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Mangan et al., 2006</xref>
###xml 137 158 137 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Veldhoen et al., 2006</xref>
###xml 433 454 433 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 456 477 456 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">McGeachy et al., 2007</xref>
###xml 479 500 479 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Stromnes et al., 2008</xref>
###xml 696 714 693 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V&#945;2.3/V&#946;8.2</italic>
###xml 882 883 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1085 1086 1053 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1132 1133 1096 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1195 1203 1156 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 1462 1480 1420 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
###xml 1548 1556 1506 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1745 1746 1703 1704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1752 1753 1710 1711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2133 2140 2088 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 2430 2437 2385 2392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 665 670 <span type="species:ncbi:10090">mouse</span>
###xml 1394 1398 <span type="species:ncbi:10090">mice</span>
###xml 1495 1499 <span type="species:ncbi:10090">mice</span>
###xml 1634 1638 <span type="species:ncbi:10090">mice</span>
###xml 1873 1877 <span type="species:ncbi:10090">mice</span>
Several recent studies have defined cytokines that induce the differentiation of Th17 cells (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006). It has also been demonstrated that myelin-specific T cells from immunized mice can be restimulated with IL-23 to enhance IL-17 production. These IL-23-driven IL-17-producing T cells can induce EAE, often with atypical clinical signs, when transferred into recipient mice (Langrish et al., 2005; McGeachy et al., 2007; Stromnes et al., 2008). However, it has not been shown whether myelin-specific Th17 cells generated in vitro with IL-6 + TGF-beta can induce EAE. Naive TCR transgenic splenocytes from a mouse that expresses TCR genes Valpha2.3/Vbeta8.2 that recognize MBP Ac1-11 were differentiated in vitro with peptide plus IL-6 + TGF-beta or IL-12. Flow cytometric analysis was used to determine the percentage of CD4+ T cells producing IFN-gamma and IL-17 under Th1-inducing (IL-12) and Th17-inducing (IL-6 + TGF-beta) conditions. Differentiation of TCR transgenic T cells with IL-12 resulted in approximately13% of CD4+ T cells expressing IFN-gamma, and >40% of CD4+ T cells differentiated with IL-6 + TGF-beta expressed IL-17 (Fig. 1 A). To determine if the Th17 cells generated by IL-6 + TGF-beta were encephalitogenic, Th17 and Th1 cells generated in vitro were transferred into naive B10.PL recipients. Although all of the mice that received Th1 cells developed EAE, as previously observed (Gocke et al., 2007), none of the mice that received the Th17 cells developed disease (Fig. 1 B). In addition, no CNS-infiltrating mononuclear cells were recovered from the mice receiving the Th17 cells. Pure populations of naive TCR transgenic T cells acquired by cell sorting of CD4+ CD62L+ cells were also differentiated in vitro with IL-6 + TGF-beta, but these cells also failed to transfer EAE to recipient mice (unpublished data). It was possible that the Th17 cells were pathogenic but unable to access the CNS in the absence of Th1 cells. However, cotransfer of myelin-specific Th17 cells with suboptimal numbers of myelin-specific Th1 cells failed to induce EAE (Table I). Although pertussis toxin is not necessary to transfer EAE with the TCR transgenic Th1 cells, perhaps pertussis toxin was necessary for trafficking of Th17 cells to the CNS. However, i.p. injection of pertussis toxin on days 0 and 2 with transfer of Th17 cells also failed to induce EAE (Table I).
###end p 8
###begin p 9
Th17 cells differentiated with IL-6 + TGF-beta are not encephalitogenic after primary stimulation
###end p 9
###begin p 10
NA, not applicable.
###end p 10
###begin p 11
Cytokine production was measured by ELISA at 72 h in culture during differentiation or following restimulation with MBP Ac1-11 only for secondary stimulation. +, <1 ng/ml; ++, 1-4 ng/ml; +++, >4 ng/ml.
###end p 11
###begin p 12
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
Mice were administered 200 ng pertussis toxin (PTX) on days 0 and 2 after transfer of Th17 (IL-6 + TGF-beta) cells into mice.
###end p 12
###begin p 13
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 68 69 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected with 5 x 106 Th17 (IL-6 + TGF-beta) cells plus 106 Th1 (IL-12) cells.
###end p 13
###begin p 14
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Th17 cells were rested for 4 d after differentiation and restimulated with MBP Ac1-11 only before transfer into naive B10.PL mice.
###end p 14
###begin p 15
###xml 62 66 <span type="species:ncbi:10090">mice</span>
The rapid onset and severity of the disease required that the mice be euthanized within 48 h of disease onset, and therefore, only the mean clinical score at the time of disease onset could be determined.
###end p 15
###begin p 16
###xml 158 162 <span type="species:ncbi:10090">mice</span>
Th17 cells (IL-6 + TGF-beta) were rested for 4 d after differentiation and restimulated with MBP Ac1-11 + IL-23 or IL-1beta before transfer into naive B10.PL mice.
###end p 16
###begin p 17
###xml 0 78 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Th17 cells differentiated in vitro with TGF-&#946; and IL-6 do not transfer EAE.</bold>
###xml 291 292 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 926 927 897 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 981 988 952 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
Th17 cells differentiated in vitro with TGF-beta and IL-6 do not transfer EAE. Naive Valpha2.3/Vbeta8.2 transgenic splenocytes were differentiated in vitro with MBP Ac1-11 plus TGF-beta + IL-6 or IL-12 for 3 d. (A) Cells were harvested and analyzed by flow cytometry. Cells were gated on CD4+ T cells, and intracellular IL-17 and IFN-gamma were analyzed. Data are representative of three independent experiments (percentages are shown). (B) Cells harvested from A were adoptively transferred into wild-type B10.PL recipient mice. Data are representative of six independent experiments (means +/- SEM). (C) Naive Valpha2.3/Vbeta8.2 transgenic splenocytes were differentiated in vitro with MBP Ac1-11 and TGF-beta + IL-6 for 3 d. The Th17 cells were rested for 4 d and restimulated with MBP Ac1-11 in the absence of exogenous cytokines for 2 d. The cells were analyzed for intracellular cytokines by flow cytometry (gated on CD4+ T cells; top) or transferred into naive B10.PL mice (Table I). CNS mononuclear cells were isolated from recipient B10.PL mice on day 7 after adoptive transfer (bottom). Flow cytometry was used to evaluate IFN-gamma- or IL-17-producing T cells. Cells were gated on CD45 and Vbeta8 TCR-positive cells. Data are representative of two independent experiments (percentages are shown).
###end p 17
###begin title 18
Th17 cells differentiated with IL-6 + TGF-beta do not have a stable phenotype
###end title 18
###begin p 19
###xml 358 379 355 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 816 823 807 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 1019 1026 1010 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 1332 1340 1319 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1654 1670 1633 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Lee et al., 2009</xref>
###xml 1849 1850 1822 1823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2028 2036 1997 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 2116 2117 2082 2083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2127 2128 2089 2090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2433 2440 2388 2395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 758 763 <span type="species:ncbi:10090">mouse</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
Because IL-6 + TGF-beta were capable of differentiating the TCR transgenic T cells into Th17 cells but failed to generate encephalitogenic T cells, we investigated the possibility that IL-23 was critical in the differentiation of pathogenic Th17 cells, because IL-23 had been shown to enhance the expansion of myelin-specific Th17 cells from immunized mice (Langrish et al., 2005). It was also possible that primary differentiation was not sufficient to generate highly encephalitogenic Th17 cells and that restimulation with antigen may be required. Therefore, TCR transgenic T cells were differentiated with MBP Ac1-11 in the presence of IL-6 + TGF-beta in the presence or absence of IL-23. These cells were transferred into naive B10.PL mice and only one mouse in the IL-6 + TGF-beta + IL-23 group developed EAE (Table I). After the primary differentiation in vitro, the Th17 cells were rested, restimulated with MBP Ac1-11, and transferred into recipient mice. All of the mice developed an early onset, severe EAE (Table I). However, analysis of the cytokine profile of the transferred T cells after secondary stimulation showed that there were actually three distinct populations of T cells generated during the restimulation: Th1 cells (37%), Th17 cells (6.6%), and a population that expressed both IFN-gamma and IL-17 (5.7%; Fig. 1 C). Thus, restimulation of the Th17 cells with antigen induced IFN-gamma production, making it unclear whether the IL-17- or IFN-gamma-producing cells caused the disease. This also suggests that Th17 cells may not have a stable phenotype, which was also observed with the OVA-specific OT-II TCR transgenic T cells (Lee et al., 2009). Therefore, the CNS-infiltrating cells, gated on CD45 and Vbeta8 (expressed by the TCR transgenic T cells), were analyzed by flow cytometry. Although three populations of Vbeta8+ T cells were identified in the CNS as defined by cytokine production, the majority (54% single positive and 13% double positive) of CNS-infiltrating T cells produced IFN-gamma (Fig. 1 C), suggesting that the severe disease was associated with an expansion of Vbeta8+ IFN-gamma+-producing cells in the CNS. In an effort to maintain the Th17 phenotype upon restimulation with antigen, IL-23 or IL-1beta were added during the restimulation with antigen, yet the cells still produced both IFN-gamma and IL-17 and transferred disease similar to the cells restimulated with antigen only (Table I).
###end p 19
###begin title 20
Role of IL-1beta and IL-23 in the differentiation of Th17 cells
###end title 20
###begin p 21
###xml 397 418 391 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 420 439 414 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">Sutton et al., 2006</xref>
###xml 782 790 770 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 1605 1613 1551 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1640 1648 1586 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1830 1838 1767 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 2205 2213 2129 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 2367 2384 2291 2308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Deng et al., 2003</xref>
###xml 2641 2649 2562 2570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 2737 2745 2658 2666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1345 1360 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1496 1500 <span type="species:ncbi:10090">mice</span>
###xml 1506 1510 <span type="species:ncbi:10090">mice</span>
###xml 1734 1738 <span type="species:ncbi:10090">mice</span>
Because IL-6 + TGF-beta were capable of differentiating T cells into IL-17-producing T cells but not sufficient to generate encephalitogenic T cells during primary stimulation, we speculated that an alternative pathway may occur in vivo that generates encephalitogenic Th17 cells. Because cytokines such as IL-1beta and IL-23 had also been implicated in the differentiation of Th17 cells and EAE (Langrish et al., 2005; Sutton et al., 2006), we investigated whether combinations of IL-6, TGF-beta, IL-1beta, and IL-23 might be required for the generation of encephalitogenic myelin-specific Th17 cells. Naive wild-type splenocytes, depleted of antigen presenting cells, were activated with plate-bound anti-CD3 + anti-CD28 with different combinations of these cytokines. As seen in Fig. 2 A, many combinations of these cytokines generated T cells capable of producing IL-17. However, in the absence of TGF-beta, IFN-gamma was also produced, suggesting that TGF-beta may be critical for suppressing IFN-gamma production, not necessarily inducing IL-17 production. Because differentiation with IL-1beta + IL-23 resulted in the greatest IL-17 production and IL-1beta + IL-23 + TGF-beta had high IL-17 and low IFN-gamma, we investigated whether these cytokine combinations may generate Th17 cells capable of inducing EAE. Splenocytes from naive TCR transgenic mice were differentiated in vitro with IL-6 + TGF-beta, IL-1beta + IL-23, IL-1beta + IL-23 + TGF-beta, or IL-12 and transferred into B10.PL mice. The mice that received the T cells differentiated with IL-12 or IL-1beta + IL-23 developed severe EAE (Fig. 2 B). As previously observed (Fig. 1 B), T cells differentiated with IL-6 + TGF-beta did not transfer disease. However, the mice that received the T cells differentiated with IL-1beta + IL-23 + TGF-beta did develop EAE (Fig. 2 B), albeit significantly milder cases than IL-12- or IL-1beta + IL-23-differentiated T cells. Analysis of the cytokines by flow cytometry at the time of transfer showed that T cells differentiated with IL-1beta + IL-23 + TGF-beta were both Th1 (9.24%) and Th17 (6.8%) cells, making it unclear whether the disease was mediated by IFN-gamma- or IL-17-producing T cells (Fig. 2 C). We have shown previously that the IL-1R signaling pathway is critical for the production of IL-12 and the differentiation of encephalitogenic T cells (Deng et al., 2003), and thus it appears that IL-1beta is up-regulating IL-12 in antigen/APC-driven differentiation, which subsequently favors Th1 cell differentiation in the presence of IL-23. This experiment also illustrates that differentiation with anti-CD3 + anti-CD28 (Fig. 2 A) generates different T cell phenotypes than antigen/APC-driven T cell differentiation (Fig. 2 C). Although this may be in part caused by cytokines produced by the APCs, it may also be caused by differences in signaling cascades mediated by natural ligands that are not accurately recapitulated by antibody-mediated signaling (unpublished data).
###end p 21
###begin p 22
###xml 0 78 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Encephalitogenicity correlates with IFN-&#947; production and T-bet expression.</bold>
###xml 783 784 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
Encephalitogenicity correlates with IFN-gamma production and T-bet expression. (A) Naive splenocytes from wild-type B10.PL mice were activated in vitro with anti-CD3/CD28 plus different combinations of cytokines for 72-96 h. ELISA was performed to detect IL-17 and IFN-gamma secretion. Data are representative of three independent experiments (means +/- SEM). (B) Naive Valpha2.3/Vbeta8.2 transgenic splenocytes were differentiated in vitro with MBP Ac1-11 plus different combinations of cytokines for 3 d and transferred into naive B10.PL mice. Data are representative of two independent of experiments (means +/- SEM). (C) Cells from B were harvested and flow cytometry was used to evaluate IFN-gamma, IL-17, IL-10, and T-bet (white, T-bet; gray, isotype control) expression in CD4+ T cells before transfer. Data are representative of two independent experiments (percentages are shown).
###end p 22
###begin p 23
###xml 179 200 176 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">McGeachy et al., 2007</xref>
###xml 340 348 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 569 570 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
It had also been suggested that in vivo-differentiated Th17 cells restimulated with IL-6 + TGF-beta induce IL-10 and, therefore, these cells may be regulatory and not pathogenic (McGeachy et al., 2007). Therefore, IL-10 was analyzed by flow cytometry in these four differentiation conditions and did not correlate with encephalitogenicity (Fig. 2 C). In fact, differentiation with IL-6 + TGF-beta generated the fewest IL-10-producing T cells. Analysis of disease severity in all four groups indicated that severity correlated with the number of IFN-gamma-expressing CD4+ T cells and expression of T-bet, the transcription factor that regulates IFN-gamma expression (). To verify that IL-6 + TGF-beta was not promoting the differentiation of regulatory T cells, TCR transgenic cells differentiated with IL-6 + TGF-beta were cotransferred with TCR transgenic cells differentiated with IL-12. As expected, the cells differentiated with IL-6 + TGF-beta did not induce EAE; however, they did not reduce the severity of EAE in Th1-mediated disease when cotransferred into mice, indicating that they do not have a regulatory phenotype ().
###end p 23
###begin title 24
Multiple cytokine combinations promote the differentiation of Th17 cells but fail to generate encephalitogenic Th17 cells
###end title 24
###begin p 25
###xml 468 489 452 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bettelli et al., 2006</xref>
###xml 491 510 475 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Mangan et al., 2006</xref>
###xml 512 533 496 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Veldhoen et al., 2006</xref>
###xml 641 649 622 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table II</xref>
###xml 1020 1026 991 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 1454 1455 1416 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
To determine to what extent IL-1beta, IL-6, IL-23, and TGF-beta contribute to the differentiation of Th17 cells and determine if any combination of these cytokines can generate encephalitogenic Th17 cells, Th17 cells were generated using all combinations of these cytokines, or neutralizing these cytokines with antibodies. Because all combinations in the absence of TGF-beta could produce IFN-gamma and TGF-beta had been implicated as necessary for IL-17 production (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006), all combinations included TGF-beta to increase the probability of generating pure Th17 cells. As seen in Table II and , the combination of all four cytokines generated the greatest number of IL-17-producing T cells and relatively few IFN-gamma T cells, but these cells, as well as all of the other combinations, failed to induce EAE when transferred into recipient mice. It is interesting to note that although IL-1beta + IL-23 + TGF-beta generated mildly encephalitogenic T cells in Fig. 2, differentiation with IL-1beta + IL-23 + TGF-beta + anti-IL-6 failed to generate encephalitogenic T cells, suggesting that endogenous IL-6 was contributing to the development of encephalitogenic T cells. Analysis of T-bet by flow cytometry indicated that T-bet was decreased >50% when IL-6 was neutralized (unpublished data). These data suggest that in vitro conditions that include TGF-beta, which are capable of producing CD4+ T cells that express high levels of IL-17, are probably not the same conditions that generate encephalitogenic Th17 cells in vivo.
###end p 25
###begin p 26
Th17 cells generated in vitro with TGF-beta fail to induce EAE
###end p 26
###begin p 27
Bolded terms indicate antibodies to a specific cytokine.
###end p 27
###begin p 28
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The percentage of cytokine-positive CD4+ T cells as determined by intracellular flow cytometric analysis. ELISA was used to measure cytokine production and correlated with the percentage of cytokine-positive CD4+ T cells.
###end p 28
###begin title 29
Myelin-specific T cells in spontaneous EAE are dependent on T-bet for encephalitogenicity
###end title 29
###begin p 30
###xml 501 509 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 670 678 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 1170 1179 1152 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table III</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 184 199 <span type="species:ncbi:10090">transgenic mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
To enhance our understanding of the characteristics of pathogenic myelin-specific T cells, we phenotyped the myelin-specific T cells in mice with spontaneous EAE. Splenocytes from TCR transgenic mice that developed spontaneous EAE were cultured with MBP Ac1-11, MBP Ac1-11 + TGF-beta, or MBP Ac1-11 + IL-6 + TGF-beta. Flow cytometric analysis demonstrated that T-bet levels were quite high (34%) in the splenocytes that received MBP Ac1-11 and inhibited in the splenocytes that had TGF-beta +/- IL-6 (Fig. 3 A). Interestingly, none of the stimulation conditions generated significant amounts of IFN-gamma, although IL-17 was detected in the presence of IL-6 + TGF-beta (Fig. 3 A). To determine if encephalitogenicity in myelin-specific T cells from mice with spontaneous EAE is dependent on T-bet, the splenocytes were transfected with siRNA-Tbet or siRNA-nonsense (NS) before activation with MBP Ac1-11 (and nontransfected, irradiated wild-type B10.PL splenocytes) and transferred into naive B10.PL mice. The majority of mice receiving the siRNA-NS-transfected cells developed EAE, whereas the mice receiving the siRNA-Tbet-transfected cells failed to develop disease (Table III). These data suggest that encephalitogenicity of myelin-specific effector T cells that arise in spontaneous EAE is dependent on T-bet for pathogenicity but not necessarily IFN-gamma, which is a downstream product of T-bet transactivation.
###end p 30
###begin p 31
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T-bet expression correlates with encephalitogenicity.</bold>
###xml 326 327 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 697 698 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1730 1731 1689 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 523 526 <span type="species:ncbi:31658">CFA</span>
###xml 1742 1747 <span type="species:ncbi:10090">mouse</span>
###xml 1783 1787 <span type="species:ncbi:10090">mice</span>
T-bet expression correlates with encephalitogenicity. (A) Splenocytes from a Valpha2.3/Vbeta8.2 transgenic mouse with spontaneous EAE were activated in vitro with MBP Ac1-11, MBP Ac1-11 plus TGF-beta, or MBP Ac1-11 plus TGF-beta/IL-6 for 3 d. Flow cytometry was used to evaluate cytokine production and T-bet expression on CD4+ T cells. Data are representative of two independent experiments (percentages are shown). (B) B6 wild-type mice were injected with siRNA-Tbet or siRNA-NS at the time of immunization with MOG35-55/CFA. The lymph nodes were removed on day 11 after immunization and stimulated with MOG 35-55 for 3 d. Flow cytometry was used to evaluate cytokine production on activated CD4+ T cells and to confirm T-bet suppression that was >95% (not depicted). Data are representative of two independent experiments (percentages are shown). (C) Naive Valpha2.3/Vbeta8.2 transgenic splenocytes were differentiated into Th17 cells in vitro with MBP Ac1-11 plus TGF-beta/IL-6 for 3 d. Cells were rested and restimulated with MBP Ac1-11 in the presence of irradiated feeders or with1 microg/ml each of plate-bound anti-CD3/CD28. After 48 h, cells were analyzed by flow cytometry. Cells were gated on CD4 and T-bet expression was analyzed in each quadrant based on IL-17 and IFN-gamma expression (gray, isotype control; white, T-bet). Data are representative of two independent experiments (percentages are shown). (D) Naive Valpha2.3/Vbeta8.2 transgenic splenocytes were differentiated into Th17 cells in vitro with MBP Ac1-11 plus TGF-beta/IL-6 for 3 d. Cells were rested for 4 d and transfected with siRNA-Tbet or siRNA-NS, followed by a 2-d restimulation with MBP Ac1-11 with nontransfected irradiated feeder cells. 5 x 106 cells per mouse were transferred into naive B10.PL mice. Data are representative of three independent experiments (means +/- SEM). (E) T-bet suppression was verified by flow cytometry. Data are representative of two independent experiments (percentages are shown). (F) ELISA was performed to detect IL-17 and IFN-gamma secretion of the cells before transfer. Data are representative of two independent experiments (means +/- SEM).
###end p 31
###begin p 32
Encephalitogenicity in spontaneous EAE is dependent on T-bet
###end p 32
###begin p 33
NA, not applicable.
###end p 33
###begin p 34
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Mean day of onset and peak mean clinical score were determined for the five mice that developed EAE.
###end p 34
###begin title 35
Role of T-bet in IL-17 expression by myelin-specific T cells
###end title 35
###begin p 36
###xml 156 174 156 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
###xml 1065 1073 1057 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 361 364 <span type="species:ncbi:31658">CFA</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
###xml 619 622 <span type="species:ncbi:31658">CFA</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
We had previously demonstrated that inhibition of T-bet with siRNA in the adoptive transfer model of EAE prevents the development of Th17 cells in the CNS (Gocke et al., 2007). However, we did not know if T-bet affected IL-17 production in myelin-specific effector T cells. We had previously found that draining lymph nodes from B6 mice immunized with MOG35-55/CFA express both Th1 and Th17 cells, as well as a small population of T cells that express both IFN-gamma and IL-17 (unpublished data). To determine if T-bet plays a role in IL-17 production in T cells generated in vivo, B6 mice were immunized with MOG35-55/CFA and administered siRNA-Tbet or siRNA-NS via the tail vein to determine if T-bet affected the phenotype of the myelin-specific T cells that differentiated in vivo. The draining lymph nodes were removed 12 d later and stimulated with MOG35-55. Flow cytometric analysis demonstrated that the number of IFN-gamma-expressing cells was reduced by 65% and that there were no detectable IL-17-producing T cells from the mice treated with siRNA-Tbet (Fig. 3 B). These data indicate that inhibition of T-bet suppresses the differentiation and/or expansion of both Th1 and Th17 cells.
###end p 36
###begin p 37
###xml 104 112 101 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 248 249 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 257 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 304 312 293 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 551 558 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 662 663 648 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 846 854 824 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 889 890 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1621 1629 1595 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 1706 1714 1680 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 1868 1876 1838 1846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 F</xref>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
###xml 1413 1417 <span type="species:ncbi:10090">mice</span>
Because myelin-specific TCR transgenic T cells differentiated with IL-6 + TGF-beta do not transfer EAE (Fig. 1 B), but restimulation of these cells with antigen only generates highly encephalitogenic T cells composed of three populations, IFN-gamma+, IL-17+, and IFN-gamma/IL-17 double-positive T cells (Fig. 1 C), we determined the expression of T-bet in these three T cell populations. Naive myelin-specific TCR transgenic T cells were differentiated with MBP Ac1-11 + IL-6 + TGF-beta, rested, and restimulated with MBP Ac1-11 only, as described in Table I, or anti-CD3/CD28. The cells were analyzed by flow cytometry to determine the level of T-bet in the CD4+ T cells. The cells that produced IFN-gamma or IL-17 only had similar levels of T-bet, yet the cells that expressed both IFN-gamma and IL-17 had significantly higher levels of T-bet (Fig. 3 C). Although the percentage of IL-17+ T cells was higher with anti-CD3/CD28 restimulation, IFN-gamma expression was similar with antigen/APC or anti-CD3/CD28 restimulation, indicating that the APCs were not responsible for the shift in cytokine production. In addition, the Th17 cells differentiated with antigen/APCs were transfected with siRNA-Tbet or siRNA-NS after the rest and before restimulation with MBP Ac1-11 and transferred into naive B10.PL mice. As expected, the mice that received the siRNA-NS-transfected cells developed severe EAE, whereas the mice that received the siRNA-Tbet-transfected cells had a significantly milder disease course (P = 0.002), suggesting that suppressing T-bet was beneficial in ameliorating EAE mediated by Th1 and Th17 cells (Fig. 3 D). Flow cytometric analysis was used to verify efficient silencing of T-bet (Fig. 3 E) and analysis of cytokine production demonstrated that the amount of IL-17 was not altered by inhibiting T-bet, and IFN-gamma was only modestly reduced (Fig. 3 F). These data indicate that although cytokine expression was not significantly altered in the effector T cells by reduced T-bet expression, suppression of T-bet was able to ameliorate T cell effector function.
###end p 37
###begin title 38
Encephalitogenic Th17 cells express T-bet
###end title 38
###begin p 39
###xml 207 210 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 479 480 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 553 561 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 708 709 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 785 793 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 824 825 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 830 831 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 987 995 979 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1148 1149 1140 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1157 1165 1149 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1193 1194 1185 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1247 1248 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1313 1314 1301 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1539 1547 1524 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1555 1556 1540 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1567 1568 1548 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1656 1657 1637 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1662 1663 1643 1644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1671 1672 1652 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1681 1682 1658 1659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1740 1741 1717 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1756 1757 1729 1730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1780 1788 1753 1761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 1808 1809 1781 1782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1814 1815 1787 1788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1824 1825 1793 1794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 246 249 <span type="species:ncbi:31658">CFA</span>
###xml 1500 1504 <span type="species:ncbi:10090">mice</span>
Because IFN-gamma-deficient mice develop EAE and develop encephalitogenic Th17 and not Th1 cells, we examined whether the CNS-infiltrating T cells coexpressed IL-17 and T-bet. EAE was induced in B6/IFN-gamma-/- mice by immunization with MOG35-55/CFA and the mononuclear cells were isolated from the CNS during acute disease. The cells were incubated overnight with or without MOG35-55, and PMA/ionomycin was added to both cultures for the final 5 h. IL-17 was produced by the CD4+ T cells and expression was enhanced in the cells that received antigen (Fig. 4 A), indicating that the IL-17-producing T cells were specific for the immunizing antigen. Similarly, T-bet was expressed by the CNS-infiltrating CD4+ T cells, and T-bet expression was higher in the MOG35-55-stimulated cells (Fig. 4 B). Analysis of T-bet in the CD4+IL-17+ T cells demonstrated that T-bet expression was almost threefold higher in the antigen-stimulated cells compared with the cells stimulated without antigen (Fig. 4 C, right), illustrating that T-bet was expressed by the MOG35-55-specific Th17 cells in the CNS. Interestingly, there was no T-bet expression in the IL-17- cells (Fig. 4 C, left), indicating that CD4+ T cells were not differentiating toward an IFN-gamma- Th1 phenotype. To determine if T-bet was also expressed in IL-17+ T cells in the CNS in adoptive transfer EAE, TCR transgenic cells were differentiated into Th17 cells with IL-6 + TGF-beta, rested, restimulated with antigen and transferred into naive mice. Similar to previous experiments (Fig. 1 C), IL-17+, IFN-gamma+, and double-positive T cells were found in the CNS cells. T-bet was observed in the CD4+IL-17+ and CD4+IFN-gamma+ T cells, indicating that T-bet was expressed in the IL-17+- and IFN-gamma+-infiltrating T cells (Fig. 4 D). The number of CD4+IL-17+IFN-gamma+ T cells was too low to accurately determine T-bet expression in this population.
###end p 39
###begin p 40
###xml 0 87 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myelin-specific T cells in the CNS of IFN-&#947;&#8211;deficient mice express IL-17 and T-bet.</bold>
###xml 119 122 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 653 654 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 659 660 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 668 669 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 674 675 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1020 1021 1005 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1035 1036 1016 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 172 175 <span type="species:ncbi:31658">CFA</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
Myelin-specific T cells in the CNS of IFN-gamma-deficient mice express IL-17 and T-bet. EAE was induced in B6/IFN-gamma-/- mice by immunization with MOG35-55 emulsified in CFA. The CNS-infiltrating mononuclear cells were isolated from the brains and spinal cords of 14 mice 5 d after the mice began to develop signs of EAE. The cells were cultured overnight with or without 2 microg/ml MOG35-55. PMA/ionomycin was added to all cells during the last 5 h of culture. Cells were gated on CD45 and CD4. (A) Intracellular IL-17 expression. (B) Intracellular T-bet expression (white, T-bet; gray, isotype control). (C) T-bet expression was analyzed in the CD4+IL-17+ and CD4+IL-17- T cells in the absence or presence of MOG35-55 (white, T-bet; gray, isotype control). (D) Naive TCR transgenic splenocytes were differentiated with IL-6 + TGF-beta, rested, restimulated with antigen, and transferred into naive B10.PL mice. Inflammatory cells were isolated in the CNS and gated on CD45 and CD4, and T-bet expression in the IL-17+ and IFN-gamma+ T cells was determined (white, T-bet; gray, isotype control). Data in A-D are representative of two independent experiments (percentages are shown).
###end p 40
###begin p 41
###xml 62 65 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 165 168 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 182 185 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 339 342 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 446 449 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 459 462 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 556 564 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 605 606 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 632 613 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 679 682 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 689 697 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 866 867 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 880 888 860 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 1035 1038 1015 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1133 1136 1109 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1372 1375 1344 1347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1413 1416 1385 1388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1424 1432 1396 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 1482 1483 1454 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1489 1490 1461 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1516 1517 1488 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1523 1524 1495 1496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1137 1141 <span type="species:ncbi:10090">mice</span>
###xml 1159 1163 <span type="species:ncbi:10090">mice</span>
###xml 1320 1324 <span type="species:ncbi:10090">mice</span>
Because T-bet-deficient mice do not develop EAE, yet IFN-gamma-/- mice are EAE susceptible, we compared the Th17 cells in these two strains of mice. B6, B6/IFN-gamma-/-, and B6/T-bet-/- mice were immunized with MOG35-55 and the draining lymph nodes were removed on day 12. Because CNS-infiltrating cells could not be analyzed because T-bet-/- mice do not develop EAE, flow cytometric analysis was performed on the lymph node cells. Both IFN-gamma-/- and T-bet-/- mice had significantly more activated MOG35-55-specific Th17 cells than the B6 control mice (Fig. 5 A). T-bet expression was higher in the CD4+ T cells from IFN-gamma-/- mice compared with B6 mice and absent in T-bet-/- mice (Fig. 5 B), which correlates with the observation that IFN-gamma-deficient mice develop more severe EAE than wild-type mice. In addition, T-bet was expressed in the activated CD4+ Th17 cells (Fig. 5 C), illustrating that T-bet is expressed by Th17 cells differentiated in vivo that cause EAE. The fact that the draining lymph node cells from T-bet-/- mice (EAE-resistant mice) express similar levels of IL-17 in the absence of T-bet as IFN-gamma-/- mice (EAE-susceptible mice) indicates that T-bet is a critical factor for determining the encephalitogenicity of Th17 cells. In addition, the cells were transferred into wild-type B6 mice, and EAE was induced by the B6 and B6/IFN-gamma-/- MOG35-55 T cells but not the B6/T-bet-/- cells (Fig. 5 D), confirming the encephalitogenicity of the T-bet+ IL-17+ T cells but not the T-bet- IL-17+ T cells.
###end p 41
###begin p 42
###xml 9 12 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 25 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 104 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IFN-&#947;<sup>&#8722;/&#8722;</sup> and T-bet<sup>&#8722;/&#8722;</sup> mice generate myelin-specific Th17 cells, although EAE susceptibility differs.</bold>
###xml 121 124 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 138 141 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 387 389 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 455 456 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 567 568 559 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 610 611 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 616 617 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 664 667 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 681 684 669 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 190 193 <span type="species:ncbi:31658">CFA</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
IFN-gamma-/- and T-bet-/- mice generate myelin-specific Th17 cells, although EAE susceptibility differs. B6, B6/IFN-gamma-/-, and B6/T-bet-/- mice were immunized with MOG35-55 emulsified in CFA. The draining lymph nodes of three mice per group were removed on day 12 and cultured with MOG35-55 for 3 d. (A) Cells were gated on CD4 and IL-17 expression was analyzed in the activated (CD44hi) T cells (percentages are shown). (B) T-bet expression in the CD4+ T cells was analyzed (white, T-bet; gray, isotype control; percentages are shown). (C) The percentage of T-bet+ cells was determined by gating on the CD4+IL-17+ T cells. (D) Splenocytes from B6, B6/IFN-gamma-/-, and B6/T-bet-/- mice immunized with MOG35-55 were stimulated in vitro with MOG35-55 and transferred into wild-type B6 mice and monitored for EAE development. Data are representative of two independent experiments (means +/- SEM).
###end p 42
###begin title 43
IL-6 promotes the differentiation of encephalitogenic Th17 cells
###end title 43
###begin p 44
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 260 261 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 267 268 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 511 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 716 724 699 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 1020 1021 990 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1063 1071 1029 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 1115 1123 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 D</xref>
###xml 1199 1207 1165 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 E</xref>
To determine the cytokines that promote the differentiation of T-bet+ IL-17+ T cells, we analyzed T-bet expression by flow cytometry in TCR transgenic splenocytes differentiated with antigen/APCs and IL-6, IL-1beta, and/or IL-23 in the absence of TGF-beta. CD4+ T-bet+ T cells were gated, and IL-17 and IFN-gamma expression was analyzed. Although IFN-gamma was observed under all cytokine conditions and is also seen with antigen-only differentiation, IL-17 was only observed with IL-6 differentiation (Fig. 6 A). Therefore, we compared IL-17 production by ELISA when the TCR transgenic cells were differentiated with IL-6 versus IL-6 + TGF-beta and found that the amount of IL-17 was similar under both conditions (Fig. 6 B). To generate pure populations of Th17 cells that express T-bet, TCR transgenic splenocytes were differentiated with IL-6 +/- TGF-beta in the presence of neutralizing antibodies to IFN-gamma, IL-12, and IL-4. Differentiation with IL-6 in the absence of IFN-gamma, IL-12, and IL-4 generated IL-17+ IFN-gamma- T cells that expressed T-bet (Fig. 6 C). IL-17 production was confirmed by ELISA (Fig. 6 D). The Th17 cells generated with IL-6 induced disease similar to Th1 cells (Fig. 6 E), suggesting that IL-6, in the absence of exogenous TGF-beta, promotes the differentiation of encephalitogenic Th17 cells.
###end p 44
###begin p 45
###xml 0 104 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6, in the absence of exogenous TGF-&#946;, promotes the differentiation of encephalitogenic Th17 cells.</bold>
###xml 248 249 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 330 331 317 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 337 338 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 994 995 961 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
###xml 1006 1011 <span type="species:ncbi:10090">mouse</span>
IL-6, in the absence of exogenous TGF-beta, promotes the differentiation of encephalitogenic Th17 cells. (A) Naive TCR transgenic splenocytes were differentiated with MBPAc1-11 and IL-6, IL-1beta, IL-23, or IL-1beta + IL-23. Cells were gated on CD4+ T cells and T-bet expression was analyzed. IFN-gamma and IL-17 expression on CD4+ T-bet+ cells was then analyzed (percentages are shown). (B) Naive TCR transgenic splenocytes were differentiated with IL-6, TGF-beta, or both and cytokine production was determined by ELISA from the supernatants (means +/- SEM). (C) Naive TCR transgenic splenocytes were differentiated with IL-12 or IL-6 (+/-TGF-beta) in the presence of neutralizing antibodies for IFN-gamma, IL-12, and IL-4. Flow cytometry analyzed IL-17, IFN-gamma, and T-bet expression in these cells (percentages are shown). (D) ELISA was used to measure cytokine expression from supernatants of cells in C (means +/- SEM). (E) The cells in D were transferred into naive B10.PL mice (5 x 106 cells per mouse) and monitored for development of EAE. Data are representative of three independent experiments (means +/- SEM).
###end p 45
###begin p 46
###xml 425 426 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 637 606 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 690 691 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 864 872 834 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 886 894 856 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1212 1220 1162 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 1365 1366 1308 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1376 1377 1319 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1461 1469 1404 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 1513 1514 1456 1457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1739 1755 1671 1687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 (C and D)</xref>
###xml 1904 1912 1833 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1973 1988 1902 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7, A and C</xref>
###xml 2105 2106 2027 2028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2318 2326 2236 2244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 2331 2340 2249 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table III</xref>
###xml 2572 2573 2486 2487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2769 2777 2675 2683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 D</xref>
###xml 81 87 <span type="species:ncbi:9913">bovine</span>
###xml 2230 2245 <span type="species:ncbi:10090">transgenic mice</span>
Because the amount of IL-17 was reduced in the absence of exogenous TGF-beta and bovine serum may contain TGF-beta that may contribute to the differentiation of Th17 cells with IL-6, the experiment was repeated with a neutralizing antibody to TGF-beta included during the T cell differentiation. Using threefold higher amounts of anti-TGF-beta than recommended by the manufacturer, we found that T-bet levels in the total CD4+ population were higher in the T cells differentiated with IL-6 + anti-IL-12/IFN-gamma/IL-4 with anti-TGF-beta than T-bet levels in the T cells differentiated with IL-6 + anti-IL-12/IFN-gamma/IL-4 only (Fig. 7 A, top). However, the amount of IL-17 expressed by CD4+ T cells was very low by intracellular cytokine staining and decreased by 50% by ELISA in the presence of anti-TGF-beta compared with IL-6 + anti-IL-12/IFN-gamma/IL-4 only (Fig. 7 A, middle; and Fig. 7 B), indicating that TGF-beta was contributing to the amount of IL-17 produced. Transfer of TCR transgenic T cells differentiated with IL-6 + TGF-beta, IL-6 + anti-IL-12/IFN-gamma/IL-4, and IL-6 + anti-IL-12/IFN-gamma/IL-4/TGF-beta demonstrates that omitting or neutralizing TGF-beta-generated encephalitogenic T cells (Fig. 7 C). Neutralization of all active TGF-beta in the cultures was confirmed by ELISA (unpublished data). Analysis of T-bet expression in the IFN-gamma+ and IL-17+ T cells demonstrates that T-bet is present in encephalitogenic T cell populations (Fig. 7 A, bottom). However, the low numbers of IL-17+ T cells in IL-6 + anti-IL-12/IFN-gamma/IL-4/TGF-beta differentiation precluded analysis of this population. There was no IFN-gamma production, as measured by ELISA, by T cells differentiated with IL-6 under any condition in Fig. 7 (C and D) (not depicted). The amount of IL-17 produced, as measured by ELISA, in the presence of IL-6 clearly correlated with the amount of TGF-beta present (Fig. 7 B), and encephalitogenicity correlated with T-bet expression (Fig. 7, A and C). The observation that differentiation with IL-6 + anti-IL-12/IFN-gamma/IL-4/TGF-beta generates encephalitogenic CD4+ T cells that express low IL-17, no IFN-gamma, and high T-bet is quite similar to our observation in spontaneous EAE in TCR transgenic mice in which T-bet levels are high yet cytokine production is undetectable (Fig. 3 A and Table III), supporting a critical role for T-bet in encephalitogenic T cells regardless of IFN-gamma and IL-17 expression. Ex vivo analysis of these encephalitogenic IL-6-differentiated T cells found that the majority of CNS-infiltrating CD4+ T cells expressed neither IFN-gamma or IL-17 (94%), but there was a small population expressing IFN-gamma (5.2%), indicating that reexposure to antigen in vivo may influence cytokine expression (Fig. 7 D).
###end p 46
###begin p 47
###xml 0 115 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGF-&#946; contributes to IL-17 expression but not the encephalitogenic capacity of T cells differentiated with IL-6.</bold>
###xml 386 387 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 473 474 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 622 623 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1001 1002 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1013 1018 <span type="species:ncbi:10090">mouse</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
TGF-beta contributes to IL-17 expression but not the encephalitogenic capacity of T cells differentiated with IL-6. Naive TCR transgenic splenocytes were differentiated with IL-12 (Th1), IL-6 + TGF-beta + anti-IL-12/IFN-gamma/IL-4, IL-6 + anti-IL-12/IFN-gamma/IL-4, or IL-6 + anti-IL-12/IFN-gamma/IL-4/TGF-beta. (A) T-bet (white histogram; gray, isotype control) expression in total CD4+ T cells was determined by flow cytometry (top). IL-17 and IFN-gamma expression in CD4+ T cells was determined (middle). IFN-gamma and IL-17 were gated on and T-bet levels were determined in each population. Because the number of IL-17+ T cells was low with IL-6 + anti-IL-12/IFN-gamma/IL-4/TGF-beta differentiation, T-bet levels could not accurately be determined. (B) IL-17 levels from the supernatants from A were determined by ELISA. IFN-gamma levels were undetectable in all IL-6 cultures (not depicted; means +/- SEM). (C) The T cell populations differentiated with IL-6 were transferred in to B10.PL (5 x 106 cells per mouse) and monitored for EAE development (means +/- SEM). (D) The CNS-infiltrating cells were isolated from the mice receiving the IL-6-differentiated (neutralizing other cytokines) T cells on day 12 after transfer. The cells were stimulated in vitro overnight with MBPAc1-11, and intracellular IFN-gamma and IL-17 were analyzed by flow cytometry. Data in A-D are representative of two independent experiments.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 307 328 307 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 330 351 330 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">McGeachy et al., 2007</xref>
###xml 353 374 353 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Stromnes et al., 2008</xref>
###xml 580 601 576 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">McGeachy et al., 2007</xref>
###xml 603 624 599 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Stromnes et al., 2008</xref>
###xml 731 752 727 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bettelli et al., 2006</xref>
###xml 754 773 750 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Mangan et al., 2006</xref>
###xml 775 796 771 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Veldhoen et al., 2006</xref>
###xml 1287 1308 1273 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 210 213 <span type="species:ncbi:31658">CFA</span>
###xml 926 941 <span type="species:ncbi:10090">transgenic mice</span>
This study was initiated to determine the role of myelin-specific Th17 cells in EAE pathogenesis. Previous EAE studies had demonstrated that Th17 cells generated in vivo by immunization with myelin peptides in CFA could be expanded in vitro with IL-23 and induce EAE when transferred into naive recipients (Langrish et al., 2005; McGeachy et al., 2007; Stromnes et al., 2008). However, these studies never excluded the possibility that myelin-specific Th1 cells were also being transferred, and two studies actually show that IFN-gamma is produced by the transferred populations (McGeachy et al., 2007; Stromnes et al., 2008). In addition, several studies had identified conditions that promoted the differentiation of Th17 cells (Bettelli et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006) yet had not determined if these differentiation conditions actually yielded encephalitogenic T cells. Using myelin-specific TCR transgenic mice that are housed in a specific pathogen-free environment, T cells were differentiated with TGF-beta and combinations of IL-1beta, IL-6, and IL-23. Although several cytokine combinations generated myelin-specific T cells that expressed high levels of IL-17 in the absence of IFN-gamma, these Th17 cells failed to induce EAE. As others have shown (Langrish et al., 2005), we found that in vivo-differentiated Th17 cells that are expanded in vitro with IL-23 are highly encephalitogenic (unpublished data), suggesting that myelin-specific Th17 cells contribute to disease pathogenesis. Thus, it appears that an alternative differentiation pathway generates encephalitogenic autoreactive Th17 cells in vivo.
###end p 49
###begin p 50
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
Because myelin-specific Th17 cells differentiated in vitro with IL-6 + TGF-beta were not pathogenic after primary differentiation, we speculated that they may be inefficient effector T cells until reexposure to antigen. However, restimulation of Th17 cells generated in vitro resulted in decreased IL-17 production and increased IFN-gamma production, suggesting that Th17 cells may not have a stable phenotype. In addition, these cells transferred disease, but it was not clear whether the disease was caused by IFN-gamma-, IL-17-, or IFN-gamma/IL-17-producing T cells because all were present in the transferred cells. Because identification of IFN-gamma- and IL-17-producing cells requires intracellular cytokine staining, it is not possible to sort these cells and transfer each population into recipient mice to identify the pathogenic T cell population. However, we were able to isolate the T cells from the CNS of these mice after disease onset and found that the majority of the myelin-specific T cells in the CNS produced IFN-gamma.
###end p 50
###begin p 51
###xml 214 215 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 420 441 413 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">McGeachy et al., 2007</xref>
###xml 1345 1365 1321 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Gorelik et al., 2002</xref>
###xml 1367 1384 1343 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Park et al., 2005</xref>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
Because production of IL-17 was not sufficient for encephalitogenicity in our study but IFN-gamma was consistently associated with disease, we analyzed other factors that may determine whether a myelin-specific CD4+ T cell population was encephalitogenic. One study suggested that IL-6 + TGF-beta may not generate pathogenic Th17 cells, because myelin-specific T cells restimulated with these cytokines expressed IL-10 (McGeachy et al., 2007). In that study, myelin-specific T cells from immunized mice were restimulated in vitro with IL-6 + TGF-beta +/- IL-23 and analyzed for cytokine expression by flow cytometry, and it was found that the cells failed to transfer disease. However, cotransfer of these IL-10-producing cells with encephalitogenic T cells protected mice from EAE, suggesting that the cells were regulatory. In our study, we found no association between IL-10 production and encephalitogenicity in T cells undergoing primary differentiation with IL-6 + TGF-beta. In fact, IL-10 expression was lowest in the T cells differentiated with IL-6 + TGF-beta. Cotransfer of Th1 cells with Th17 cells differentiated with IL-6 + TGF-beta did not protect mice from EAE (Fig. S1). In contrast, T-bet expression had the highest correlation with encephalitogenicity. Thus, we speculate that TGF-beta, a known antagonist of T-bet expression (Gorelik et al., 2002; Park et al., 2005), may be responsible for minimizing the encephalitogenic capacity of myelin-specific Th17 cells generated in vitro with IL-6 + TGF-beta.
###end p 51
###begin p 52
###xml 127 128 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 138 156 134 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Szabo et al., 2000</xref>
###xml 236 257 232 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Bettelli et al., 2004</xref>
###xml 259 284 255 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Lovett-Racke et al., 2004</xref>
###xml 286 303 282 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Nath et al., 2006</xref>
###xml 305 323 301 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
###xml 373 396 369 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Harrington et al., 2005</xref>
###xml 398 417 394 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Furuta et al., 2008</xref>
###xml 419 437 415 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Phoon et al., 2008</xref>
###xml 583 603 579 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Neurath et al., 2002</xref>
###xml 605 622 601 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Peng et al., 2002</xref>
###xml 624 645 620 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Bettelli et al., 2004</xref>
###xml 647 666 643 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Juedes et al., 2004</xref>
###xml 668 685 664 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Nath et al., 2006</xref>
###xml 687 704 683 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Wang et al., 2006</xref>
###xml 1077 1094 1073 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">Nath et al., 2006</xref>
###xml 1790 1796 1776 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-23R</italic>
###xml 1803 1821 1789 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
###xml 1893 1913 1879 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Oppmann et al., 2000</xref>
###xml 1915 1934 1901 1920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Parham et al., 2002</xref>
###xml 2040 2061 2026 2047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Aggarwal et al., 2003</xref>
###xml 2063 2084 2049 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Langrish et al., 2005</xref>
###xml 2086 2107 2072 2093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Stromnes et al., 2008</xref>
###xml 2605 2621 2591 2607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Cua et al., 2003</xref>
###xml 2794 2795 2780 2781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2962 2981 2948 2967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Chabas et al., 2001</xref>
###xml 2983 3003 2969 2989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Jansson et al., 2002</xref>
###xml 3005 3027 2991 3013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Shinohara et al., 2005</xref>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
###xml 1342 1346 <span type="species:ncbi:10090">mice</span>
###xml 2504 2508 <span type="species:ncbi:10090">mice</span>
###xml 2919 2923 <span type="species:ncbi:10090">mice</span>
T-bet is a transcription factor that was first associated with the differentiation of Th1 cells and IFN-gamma production by CD4+ T cells (Szabo et al., 2000). We and others have found that T-bet is essential for the development of EAE (Bettelli et al., 2004; Lovett-Racke et al., 2004; Nath et al., 2006; Gocke et al., 2007) even though T-bet-deficient mice produce IL-17 (Harrington et al., 2005; Furuta et al., 2008; Phoon et al., 2008). In fact, several models of autoimmunity in which IL-17 has been implicated as a pathogenic cytokine are not inducible in T-bet-deficient mice (Neurath et al., 2002; Peng et al., 2002; Bettelli et al., 2004; Juedes et al., 2004; Nath et al., 2006; Wang et al., 2006). These observations suggest that the generation of autoreactive Th17 cells in the absence of T-bet is not sufficient to induce autoimmunity, even when the Th17 cells are differentiated in vivo. Myelin-specific T cells from T-bet-deficient mice fail to transfer disease to wild-type mice, confirming that T-bet is necessary for the generation of encephalitogenic T cells (Nath et al., 2006). Encephalitogenic T cells differentiated in vitro with IL-12 or IL-1beta + IL-23 expressed high levels of T-bet, whereas addition of TGF-beta consistently reduced T-bet expression and encephalitogenic capacity. When T-bet levels were analyzed in mice with spontaneous EAE, T-bet expression was high, although these cells produced little, if any, IFN-gamma or IL-17, suggesting that T-bet may be regulating other genes or pathways that are critical for encephalitogenicity, which may be unrelated to cytokine production. We have previously shown that suppression of T-bet inhibits IL-23R expression, and that T-bet binds the IL-23R promoter and plays a direct role in the transactivation of the IL-23R gene (Gocke et al., 2007). Historically, IL-23R was identified as a marker of memory Th1 cells (Oppmann et al., 2000; Parham et al., 2002), although the more recent literature suggests that the IL-23R pathway is critical for IL-17 production (Aggarwal et al., 2003; Langrish et al., 2005; Stromnes et al., 2008). These data were ascertained by studying mRNA or how T cells responded to IL-23. Unfortunately, there is no commercial IL-23R antibody available for flow cytometric analysis to definitively determine the cell populations that express this receptor and how the engagement of the IL-23R affects cytokine production and pathogenicity by Th1 or Th17 cells. However, it is clear that IL-23-deficient mice do not develop EAE, and thus, IL-23R engagement is critical in the pathogenesis of the disease (Cua et al., 2003). Therefore, it is possible that T-bet up-regulates IL-23R expression and that engagement of the IL-23R, whether on Th1 or Th17 cells, generates highly encephalitogenic CD4+ T cells. However, other genes such as osteopontin have also been shown to be regulated by T-bet, and osteopontin-deficient mice have a reduced susceptibility to EAE (Chabas et al., 2001; Jansson et al., 2002; Shinohara et al., 2005), necessitating a comprehensive analysis of genes transactivated by T-bet and their contribution to T cell encephalitogenicity.
###end p 52
###begin p 53
###xml 565 568 553 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 746 763 734 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Chen et al., 2006</xref>
###xml 878 881 862 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1082 1085 1066 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1164 1167 1144 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1596 1599 1576 1579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1613 1616 1589 1592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 340 343 <span type="species:ncbi:31658">CFA</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
###xml 1168 1172 <span type="species:ncbi:10090">mice</span>
###xml 1362 1366 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
###xml 1557 1561 <span type="species:ncbi:10090">mice</span>
###xml 1617 1621 <span type="species:ncbi:10090">mice</span>
###xml 1676 1680 <span type="species:ncbi:10090">mice</span>
The critical role of T-bet for encephalitogenicity was observed when siRNA was used to silence T-bet in highly encephalitogenic T cells that express both IFN-gamma and IL-17, resulting in the reduced pathogenic potential of these myelin-specific T cells. In addition, administration of T-bet siRNA to mice immunized with myelin peptides in CFA reduces both IFN-gamma and IL-17 production, suggesting that T-bet's role in T cell differentiation is not limited to Th1 cells. We confirmed this observation by analyzing myelin-specific T cells from the CNS of IFN-gamma-/- mice that express both IL-17 and T-bet. In IL-23-driven IL-17-producing T cells from myelin-immunized mice, T-bet was also observed in these pathogenic IL-17-producing T cells (Chen et al., 2006). Analysis of the draining lymph nodes after active induction of EAE demonstrated that the Th17 cells in IFN-gamma-/- mice express higher levels of T-bet than wild-type controls, which suggest that encephalitogenicity is associated with enhanced T-bet expression. The fact that the draining lymph node cells from T-bet-/- mice express similar levels of Th17 cells in the absence of T-bet as IFN-gamma-/- mice indicates that T-bet is a critical factor for determining encephalitogenicity, not IL-17 expression. It is also interesting to note that systemic administration of T-bet siRNA in wild-type mice suppresses development of Th17 cells, whereas immunization of mice with a genetic deletion of T-bet results in a significant population of nonencephalitogenic Th17 cells. This suggests that mice incapable of generating Th1 (T-bet-/- and IFN-gamma-/- mice) promote Th17 cell differentiation but that wild-type mice in which T-bet is suppressed via siRNA do not favor Th17 cell differentiation, possibly because of Th1-related cytokines that are still present at low levels in the environment.
###end p 53
###begin p 54
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 755 756 740 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 930 947 915 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Wang et al., 2006</xref>
###xml 1018 1019 1003 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
It was still unclear how T-bet+ IL-17+ encephalitogenic T cells could be generated if TGF-beta was critical for development of Th17 cells. However, IL-6, in the absence of exogenous TGF-beta and Th1-associated cytokines, promoted the differentiation of encephalitogenic Th17 cells that expressed T-bet. This confirmed that myelin-specific Th17 cells can induce EAE, but that T-bet must be expressed either by differentiation in a TGF-beta-low environment or differentiation with IL-6 + TGF-beta and reexposure to antigen in a TGF-beta-low environment to allow for up-regulation of T-bet. The data in this study clearly define the necessity of T-bet in the development of autoimmune demyelinating disease, but they do not exclude the possibility that T-bet- T cells contribute to pathogenesis. In addition, T-bet may be contributing to disease in multiple cell types, such as dendritic cells as observed in inflammatory arthritis (Wang et al., 2006), although this study focuses specifically on the role of T-bet in CD4+ T cells.
###end p 54
###begin p 55
###xml 263 264 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 422 441 418 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Ferber et al., 1996</xref>
###xml 443 464 439 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Komiyama et al., 2006</xref>
###xml 466 483 462 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Haak et al., 2009</xref>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
Although this study was initially designed to determine the role of myelin-specific Th1 and Th17 cells in EAE pathogenesis, we have found that pathogenesis is more closely associated with a transcription factor than cytokine production. We typically associate CD4+ T cell function with the cytokines that they produce. However, both IFN-gamma- and IL-17-deficient mice develop EAE, although the disease course is altered (Ferber et al., 1996; Komiyama et al., 2006; Haak et al., 2009). In the case of autoimmunity, the function of autoreactive T cells may be mediated by a particular signaling pathway (i.e., T-bet) that programs the cells to be pathogenic, and not the end product of a pathway (i.e., cytokine production).
###end p 55
###begin title 56
MATERIALS AND METHODS
###end title 56
###begin title 57

###end title 57
###begin title 58
Induction of EAE.
###end title 58
###begin p 59
###xml 153 174 146 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Goverman et al., 1993</xref>
###xml 201 204 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 218 221 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 643 646 <span type="species:ncbi:31658">CFA</span>
###xml 683 688 <span type="species:ncbi:10090">mouse</span>
###xml 758 762 <span type="species:ncbi:10090">Mice</span>
B10.PL mice transgenic for the MBP Ac1-11-specific TCR chains Valpha2.3 or Vbeta8.2 were a gift from J. Goverman (University of Washington, Seattle, WA; Goverman et al., 1993). B10.PL, B6, B6/IFN-gamma-/-, and B6/T-bet-/- mice were purchased from the Jackson Laboratory and bred in a specific pathogen-free animal facility at Ohio State University (OSU) Medical Center. All animal protocols were approved by the OSU Institutional Animal Care and Use Committee. EAE was induced in 8-10-wk-old B10.PL or B6 mice by s.c. injection over four sites in the flank with 200 microg MBP Ac1-11 or MOG35-55, respectively (Invitrogen) in an emulsion with CFA (Difco). 200 ng pertussis toxin per mouse in PBS was injected i.p. at the time of immunization and 48 h later. Mice were scored on scale of 0 to 6: 0, no clinical disease; 1, limp/flaccid tail; 2, moderate hind limb weakness; 3, severe hind limb weakness; 4, complete hind limb paralysis; 5 quadriplegia or premoribund state; and 6, death.
###end p 59
###begin p 60
###xml 330 331 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 385 386 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 945 946 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 97 112 <span type="species:ncbi:10090">transgenic mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
EAE was also induced by adoptive transfer. Spleens from naive 5-10-wk-old Valpha2.3/Vbeta8.2 TCR transgenic mice were removed and single-cell suspensions were prepared. The naive status of the TCR transgenic T cells was verified by analysis of CD62 and CD44 by flow cytometry. Splenocytes were cultured in 24-well plates at 2 x 106 cells/well with irradiated B10.PL splenocytes (6 x 106 cells/well). Cells were activated with 2 microg/ml of MBP Ac1-11 and different combination of cytokines or neutralizing antibodies for cytokines to differentiate Th1 or Th17 cells. Cytokine and antibody concentrations were as follows: 0.5 ng/ml IL-12, 10 ng/ml IL-1beta, 25 ng/ml IL-6, 10 ng/ml IL-23, 1 ng/ml TGF-beta, 4.5 microg/ml anti-IL-1beta, 2 microg/ml anti-IL-6, 5 microg/ml anti-IL-23, 2 microg/ml anti-IFN-gamma, 1 microg/ml anti-IL-12, 2 microg/ml anti-IL-4, and 0.35 microg/ml anti-TGF-beta. After 72 h, the cells were washed with PBS and 5 x 106 cells were injected i.p. into naive B10.PL mice. The mice were evaluated daily for clinical signs of EAE, as described in the previous paragraph.
###end p 60
###begin title 61
Administration of siRNA in vivo and transfection with siRNA in vitro.
###end title 61
###begin p 62
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 526 551 500 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Lovett-Racke et al., 2004</xref>
###xml 898 919 868 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Bettelli et al., 2006</xref>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 308 323 <span type="species:ncbi:10090">transgenic mice</span>
###xml 787 802 <span type="species:ncbi:10090">transgenic mice</span>
Synthetic siRNA was purchased from Thermo Fisher Scientific, and stocks were prepared in the RNase-free H2O at 160 microM and diluted to 50 microg/100 microl PBS (2 mg/kg/mouse) for i.v. administration via the tail vein. For in vitro transfection of Th17 cells, splenocytes from naive Valpha2.3/Vbeta8.2 TCR transgenic mice were cultured with 2 microg/ml of MBP Ac1-11 and TGF-beta + IL-6 for 3 d to differentiate Th17 cells. The cells were rested for 4 d and transfected with siRNA-Tbet or siRNA-NS, as described previously (Lovett-Racke et al., 2004). After overnight transfection, the cells were washed and stimulated with 2 microg/ml of peptide in the presence of wild-type, nontransfected, irradiated splenocytes at a ratio of 1:5. For in vitro transfection of splenocytes from TCR transgenic mice with spontaneous EAE, the cells were transfected with siRNA overnight as previously described (Bettelli et al., 2006), washed, and activated with 2 microg/ml of MBP Ac1-11 in the presence of wild-type, nontransfected, irradiated splenocytes at a ratio of 1:5.
###end p 62
###begin title 63
Cytokine ELISA.
###end title 63
###begin p 64
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 136 137 136 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 240 241 240 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1181 1182 1133 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1183 1184 1135 1136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1282 1285 1234 1237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">405</sub>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
###xml 743 746 <span type="species:ncbi:10116">rat</span>
###xml 752 757 <span type="species:ncbi:10090">mouse</span>
Supernatants were collected from TCR transgenic splenocytes cultured at 2 x 106 cells/well with irradiated wild-type splenocytes (6 x 106 cells/well) in 24-well plates. Purified anti-mouse primary antibodies (BD) were diluted in 0.1 M NaHCO3 (pH 8.2) at 2 microg/ml. Immunolon II plates (Dynatech Laboratories) were coated with 50 microl of primary antibodies per well and incubated overnight at 4degreesC. The plates were washed twice with PBS/0.05% Tween 20. The plates were blocked with 200 microl of 1% BSA in PBS per well for 2 h. The plates were washed twice with PBS/Tween 20, and 100 microl of supernatants were added in duplicate. The plates were incubated overnight at 4degreesC and washed four times with PBS/Tween 20. Biotinylated rat anti-mouse secondary antibodies (BD) were diluted in PBS/1% BSA, 100 microl of 1-microg/ml biotinylated antibodies was added to each well, and plates were incubated at room temperature for 1 h. The plates were washed six times with PBS/Tween 20, and 100 microl avidin-peroxidase was added at 2.5 microg/ml and incubated for 30 min. The plates were washed eight times with PBS/Tween 20, and 100 microl ABTS substrate containing 0.03% H2O2 was added to each well. The plate was monitored for 10-20 min for color development and read at A405. A standard curve was generated from the IFN-gamma, IL-10, and IL-17 standards, and the concentration of IFN-gamma, IL-10, and IL-17 in the samples was calculated.
###end p 64
###begin title 65
Intracellular staining and flow cytometry.
###end title 65
###begin p 66
###xml 197 215 197 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Gocke et al., 2007</xref>
Flow cytometric analysis was performed to evaluate cytokine production and T-bet expression in splenocytes and CNS-infiltrating cells. CNS-infiltrating cells were prepared as previously described (Gocke et al., 2007). Splenocytes and/or CNS mononuclear cells were cultured with or without antigen. For the last 4-5 h of the incubation, 50 ng/ml PMA and 750 ng/ml ionomycin were added to cells. 1 microl/ml GolgiPlug was added to each well to block cytokine secretion 4 h before staining. Cells were collected, washed, and incubated with Fc block (BD) on ice for 15-20 min. The cells were washed and resuspended in staining buffer (1% BSA in PBS). The cells were incubated with mAbs to the cell-surface markers for 30 min at 4degreesC. After washing twice with staining buffer, cells were fixed and permeabilized using Cytofix/Cytoperm solution (BD) for 20 min at 4degreesC. Cells were stained for intracellular cytokines and T-bet with mAb diluted in PermWash solution for 30 min at 4degreesC. 80,000-100,000 live cell events were acquired on a FACSCalibur or FACSCanto (BD) and analyzed using FlowJo software (Tree Star, Inc.). PerCP-conjugated anti-CD45, allophycocyanin (APC)-conjugated anti-Valpha2, FITC-conjugated anti-Vbeta8, PE-conjugated anti-IL-17, APC-conjugated anti-IFN-gamma, PerCP-conjugated anti-CD4, and APC-conjugated anti-IL-10 were purchased from BD. FITC-conjugated anti-T-bet was purchased from Santa Cruz Biotechnology, Inc.
###end p 66
###begin title 67
Statistical analysis.
###end title 67
###begin p 68
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
A statistically significant difference in EAE clinical scores was considered to be P < 0.05 as determined by Mann-Whitney U test. The analysis was performed on the raw data that included all clinical scores for each mouse for each time point in each group. The Mann-Whitney U test is nonparametric and therefore accounts for the fact that EAE scores are ordinal and not interval scaled.
###end p 68
###begin title 69
Online supplemental material.
###end title 69
###begin p 70
###xml 61 67 61 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
Table S1 illustrates cytokine, T-bet and EAE data related to Fig. 2. Co-transfer of myelin-specific Th1 and Th17 cells (differentiated with IL-6 + TGF-beta) is shown in Fig. S1 illustrating the IL-6 + TGF-beta differentiated Th17 cells do not appear to regulate encephalitogenic Th1 cells. Cytokine expression of in vitro differentiation of myelin-specific T cells in presence of TGF-beta and various combinations of IL-1beta, IL-6 and IL-23, or antibodies to neutralize these cytokines, is illustrated in Fig. S2. Online supplemental material is available at .
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
[Supplemental Material]
###end title 72
###begin p 73
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
We thank Dr. C. Whitacre for her review of the data and C. Pannell for his invaluable support of our mouse studies.
###end p 73
###begin p 74
This work was supported by grants from the National Multiple Sclerosis Society (RG3812-A-3 and RG3427-A-8) and the National Institutes of Health (NS44250 and NS37513). A.E. Lovett-Racke is a National Multiple Sclerosis Society Harry Weaver Neuroscience Scholar (JF2116A1/1).
###end p 74
###begin p 75
The authors have no conflicting financial interests.
###end p 75
###begin article-title 76
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.
###end article-title 76
###begin article-title 77
###xml 46 54 <span type="species:ncbi:9606">patients</span>
T cells responsive to myelin basic protein in patients with multiple sclerosis.
###end article-title 77
###begin article-title 78
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype.
###end article-title 78
###begin article-title 79
Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.
###end article-title 79
###begin article-title 80
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
###end article-title 80
###begin article-title 81
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
###end article-title 81
###begin article-title 82
Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis.
###end article-title 82
###begin article-title 83
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
###end article-title 83
###begin article-title 84
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.
###end article-title 84
###begin article-title 85
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.
###end article-title 85
###begin article-title 86
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis.
###end article-title 86
###begin article-title 87
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
###end article-title 87
###begin article-title 88
IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity.
###end article-title 88
###begin article-title 89
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE).
###end article-title 89
###begin article-title 90
Overlapping and distinct roles of STAT4 and T-bet in the regulation of T cell differentiation and allergic airway inflammation.
###end article-title 90
###begin article-title 91
T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity.
###end article-title 91
###begin article-title 92
Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation.
###end article-title 92
###begin article-title 93
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice that express myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.
###end article-title 93
###begin article-title 94
###xml 80 84 <span type="species:ncbi:10090">mice</span>
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.
###end article-title 94
###begin article-title 95
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.
###end article-title 95
###begin article-title 96
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma.
###end article-title 96
###begin article-title 97
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice.
###end article-title 97
###begin article-title 98
T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes.
###end article-title 98
###begin article-title 99
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
###end article-title 99
###begin article-title 100
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.
###end article-title 100
###begin article-title 101
Late developmental plasticity in the T helper 17 lineage.
###end article-title 101
###begin article-title 102
Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
###end article-title 102
###begin article-title 103
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis.
###end article-title 103
###begin article-title 104
###xml 115 123 <span type="species:ncbi:9606">patients</span>
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
###end article-title 104
###begin article-title 105
Silencing T-bet defines critical role in the differentiation of autoreactive T lymphocytes.
###end article-title 105
###begin article-title 106
Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis.
###end article-title 106
###begin article-title 107
Transforming growth factor-beta induces development of the Th17 lineage.
###end article-title 107
###begin article-title 108
Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis.
###end article-title 108
###begin article-title 109
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
###end article-title 109
###begin article-title 110
T-bet is essential for the progression of experimental autoimmune encephalomyelitis.
###end article-title 110
###begin article-title 111
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.
###end article-title 111
###begin article-title 112
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
###end article-title 112
###begin article-title 113
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
###end article-title 113
###begin article-title 114
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.
###end article-title 114
###begin article-title 115
###xml 51 57 <span type="species:ncbi:10090">murine</span>
TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1.
###end article-title 115
###begin article-title 116
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production.
###end article-title 116
###begin article-title 117
T-bet regulates IgG class switching and pathogenic autoantibody production.
###end article-title 117
###begin article-title 118
T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis.
###end article-title 118
###begin article-title 119
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
###end article-title 119
###begin article-title 120
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
###end article-title 120
###begin article-title 121
T-bet-dependent expression of osteopontin contributes to T cell polarization.
###end article-title 121
###begin article-title 122
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
###end article-title 122
###begin article-title 123
Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
###end article-title 123
###begin article-title 124
A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
###end article-title 124
###begin article-title 125
A novel transcription factor, T-bet, directs Th1 lineage commitment.
###end article-title 125
###begin article-title 126
TGFbeta in the context of an inflammatory cytokine nilieu supports de novo differentiation of IL-17-producing T cells.
###end article-title 126
###begin article-title 127
###xml 41 46 <span type="species:ncbi:9606">human</span>
T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes.
###end article-title 127
###begin article-title 128
###xml 103 109 <span type="species:ncbi:10090">murine</span>
Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms.
###end article-title 128
###begin article-title 129
Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells.
###end article-title 129
###begin article-title 130
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
###end article-title 130
###begin article-title 131
Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
###end article-title 131
###begin p 132
Abbreviations used: CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; MBP, myelin basic protein; MS, multiple sclerosis; NS, nonsense.
###end p 132

